AstraZeneca is one of the largest pharmaceutical companies in the world and is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest approximately $100 million annually in research and development initiatives. Most of our 1,050 Canadian employees work at our high-tech headquarters in Mississauga, Ontario, while over 120 scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio focuses on six areas of medicine: Cancer, Cardiovascular disease, Infection, Gastrointestinal disease, Neurological disorders, Respiratory and inflammatory conditions.
Marion McCourt, President and Chief Executive Officer
Adresse :
1004 Middlegate Road
Mississauga, ON L4Y 1M4
Canada
Numéro de téléphone :
905-566-7323
AstraZeneca Canada Inc. ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement